Skip to content
DraconiticResearch
Search Sources API
206,698 studies31 sourcesUpdated 3 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. ANO6 Scaffolds ER Mitochondria Contacts to Govern Spatial Lipid Compartmentalization and Ferroptosis Evasion in Chemoresistant Breast Cancer
    Q. Yang, J. Yan, P. Zhao +5
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  2. ICOS blockade alleviates immune suppression in breast tumor microenvironment
    S. Guleria, C. D. Liyanage, W. J. Hutchison +16
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  3. Higher Remnant Cholesterol Inflammatory Index is Associated with Mortality in Patients with Lung Cancer: A UK Biobank Prospective Cohort Study with a Supportive External Cohort.
    Hongjin Wang, Jiehuan Lin, Pengtao Huang +1
    Journal of inflammation researchPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  4. Predictive and Prognostic Value of Androgen Receptor Expression Across All Molecular Subtypes in Patients with Breast Cancer Who Received Neoadjuvant-Treatment: Single-Center Retrospective Analysis.
    Harun Muğlu, Vedat Buğra Erol, Hakan Özçelik +14
    Breast cancer (Dove Medical Press)Peer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. Longitudinal AI Models Predict Cancer Adverse Events
    Chenlian Fu, Jie (Jennifer) Yu, Ruian (Ian) Shi +11
    medRxivPreprintCC BY-NCFull textOncologymedRxivPMC
  6. Clinical and prognostic significance of the C-reactive protein-albumin-lymphocyte (CALLY) index in breast cancer: a systematic review and meta-analysis
    K. Jalalian Rad, S. Kadri, A. Yakiti +4
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  7. Contralateral Axillary Lymph Node Metastases Detected by Repeat Sentinel Lymph Node Biopsy in a Patient with Ipsilateral Breast Tumor Recurrence: A Case Report.
    Naotaka Uchida, Takako Suda
    Surgical case reportsPeer-reviewedCC BYFull textOncologyEurope PMC
  8. Impact of COVID-19 restrictions on emergency bellwether procedures in South and Southeast Asia.
    Sze Ling Chan, Jia Sheng Guan, Sean Shao Wei Lam +35
    BMJ public healthPeer-reviewedCC BY-NCFull textOncologyEurope PMCDOAJ
  9. Extracavitary Primary Effusion Lymphoma in an HIV-Negative Patient With Aberrant Immunophenotypic Features.
    Gabriel Lopes Centoducatte, Mariana Di Giuseppe Deininger, Irene Lorand-Metze +1
    EJHaemPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Bidirectional relationship between diabetes and pancreatic cancer: from mechanistic investigation to clinical application
    Jiangmin Wu, Tingting Jiang, Xiaojia Li +2
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  11. Risk prediction models for fear of cancer recurrence in patients with cancer: a systematic review
    Yifan Zhang, Dongmei Wu, Wendan Xiao +6
    Frontiers in PsychiatryPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  12. Combination of antibody–drug conjugates with immunotherapy: a new paradigm in cancer treatment
    Yongli Lai, Ruyu Qin, Zhaidong Liu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  13. Lipid metabolism mediating oxaliplatin resistance in colorectal cancer
    Siqi Han, Liqiang Gu, Ziyu Ren +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  14. Acute myeloid leukemia following icotinib therapy for non-small cell lung cancer: a case report and literature review
    Huiling Huang, Lu Song, Fangqin Tong +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  15. Designing and optimizing an intelligent health informatics management platform for patients undergoing chemotherapy for breast cancer: from needs assessment to pilot testing
    Xiaosong Yu, Lin Zhang, Li Yang +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  16. Can the prognostic nutritional index predict survival in patients with gastric and esophagogastric junction adenocarcinoma?
    Mehmet Furkan Sağdıç, Burak Dinçer, Güldeniz Argun +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  17. PF chemotherapy combined with a PD-1/CTLA-4 bispecific antibody as first-line treatment in patients with recurrent/metastatic head and neck squamous cell carcinoma: a prospective, single-arm, phase II clinical study
    Wenjun Liao, Qiaohua Li, Yue Deng +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  18. Case Report: Prolonged survival following multimodal treatment of leptomeningeal metastases in triple-negative glycogen-rich clear cell breast carcinoma
    Yun-Chih Lo, Chun-Chieh Wu, Shang-Chun Hung +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  19. Editorial: The insights of multi-omics into the microenvironment after tumor metastasis: a paradigm shift in molecular targeting modeling and immunotherapy for advanced cancer patients, volume II
    Mengyan Xie, Hong Chang, Xue Zhao +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  20. The CP-STPG3-AS1 axis regulates lipoylation and cuproptosis in castration-resistant prostate cancer
    Jia Wei He, Pei Zhen Li, Zhen Zhao Zhang
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  21. The feasibility of training nnU-Net to segment pediatric Wilms tumor with small datasets
    M.A.D. Buser, R.F. Meijer, A.F.W. van der Steeg +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  22. SUMOylation counteracts ubiquitination to stabilize ANKRD1 and promote osimertinib resistance in lung adenocarcinoma
    BiaoFeng Fan, Qing Lei, HaoNan Wang +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  23. Case Report: Chronic myelomonocytic leukemia with mature plasmacytoid dendritic cell proliferation initially classified as MDS-IB2
    Junhong Chen, Juan Liu, Yanying Ren
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  24. An eight-gene prognostic signature and its immune associations in gastric cancer: integrated transcriptomic and clinical analyses
    Dong Wen, Lili Mi, Yan Zhang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  25. Nutritional anthropometric indicators predict achievable pocket depth in totally implantable venous access port implantation: a prospective study with 3D-printed measurement device
    Min Hu, Xiangrui Chen, Xiaomei He +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC